Abstract
Until date, diabetes during pregnancy has been linked to an increased risk of maternal, fetal, and neonatal morbidity and mortality. Infants of diabetic mothers (IDM) frequently have difficulties related to fetal hyperglycemia and hyperinsulinemia caused by maternal hyperglycemia. Because insulin breakdown is accelerated in the presence of mild hemolysis, cord serum C-peptide levels are utilized as an indicator of fetal beta-cell function rather than insulin levels. Objective:
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
